Skip to main content

Table 3 The short- and long-term outcomes of lymphadenectomy for lymph node recurrence

From: The impact of lymphadenectomy on lymph node recurrence after performing various treatments for esophageal squamous cell carcinoma

 

Esophagectomy (n = 11)

ER (n = 5)

CRT/CT (n = 4)

Total (n = 20)

Short-term outcomes

    

 Curability R0/R1/R2

9/1/1

4/0/1

4/0/0

17/1/2

 No. of metastatic nodes, median (range)

2 (0–29)

2 (0–6)

5 (1–8)*

2 (0–29)

 Postoperative hospital stay (days) median (range)

5 (2–26)

3 (3–15)

5 (3–13)

4.5 (2–26)

 Complication (%) (Clavien-Dindo grade II ≤)

4 (36.4)

1 (20.0)

1 (25.0)

6 (30.0)

Long-term outcomes

    

 Five-year survival rate☨ (%) (95% CI)

40.0 (12.3, 67.0)

75.0 (12.8, 96.1)

50.0 (5.8, 84.5)

50.0 (25.9, 70.1)

 Five-year relapse-free survival rate☨☨ (%) (95% CI)

25.0 (3.7, 55.8)

33.3 (0.9, 77.4)

25.0 (0.9, 66.5)

26.7 (8.7, 49.6)

  1. ER endoscopic resection, CT chemotherapy, CRT chemoradiotherapy, CI confidence interval
  2. R residual tumor
  3. *We removed one patient who had some cancer cells, but not in the lymph nodes
  4. ☨We removed two patients who had no metastatic lymph nodes on pathology
  5. ☨☨We removed two patients who had no metastatic lymph nodes on pathology and three patients for whom R0 resection could not be achieve